Haematologica (Apr 2017)
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
Abstract
B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple myeloma patients. Compared to healthy donors, patients with multiple myeloma showed elevated serum B-cell maturation antigen levels (P